Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type I reverse transcriptase
| Authors |
|
|---|---|
| Publication date | 1997 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | Issue number | 41 |
| Pages (from-to) | 2484-2491 |
| Organisations |
|
| Document type | Article |
| Downloads | |
| Permalink to this page | |